Item Type | Name |
Academic Article
|
Definitive radiation therapy for squamous cell carcinoma of the vagina.
|
Academic Article
|
Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy.
|
Academic Article
|
Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer.
|
Academic Article
|
Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125.
|
Academic Article
|
Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy.
|
Academic Article
|
Knife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostate.
|
Academic Article
|
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States.
|
Academic Article
|
Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure.
|
Academic Article
|
An MRI-based dose--reponse analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trial.
|
Academic Article
|
A novel MRI marker for prostate brachytherapy.
|
Academic Article
|
Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management.
|
Academic Article
|
Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience.
|
Academic Article
|
The impact of acute urinary retention after iodine-125 prostate brachytherapy on health-related quality of life.
|
Academic Article
|
Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy.
|
Academic Article
|
Outcomes after prostate brachytherapy are even better than predicted.
|
Academic Article
|
Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy.
|
Academic Article
|
Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy.
|
Academic Article
|
Magnetic resonance imaging-based treatment planning for prostate brachytherapy.
|
Academic Article
|
A biodistribution and toxicity study of cobalt dichloride-N-acetyl cysteine in an implantable MRI marker for prostate cancer treatment.
|
Academic Article
|
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.
|
Academic Article
|
Long-term tumor control after brachytherapy for base-of-prostate cancer.
|
Academic Article
|
An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
|
Academic Article
|
Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?
|
Academic Article
|
Treatment of recurrent vaginal melanoma with external beam radiation therapy and palladium-103 brachytherapy.
|
Academic Article
|
Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy.
|
Academic Article
|
Subacute penile numbness after brachytherapy for prostate cancer.
|
Academic Article
|
Prostate specific antigen bounce is related to overall survival in prostate brachytherapy.
|
Academic Article
|
Displacement of periurethral stranded seeds and its dosimetric consequences in prostate brachytherapy.
|
Academic Article
|
American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer.
|
Concept
|
Brachytherapy
|
Academic Article
|
Improving prostate brachytherapy quality assurance with MRI-CT fusion-based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancer.
|
Academic Article
|
MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a phase II prospective trial of men with intermediate-risk localized prostate cancer.
|
Academic Article
|
Declining use of brachytherapy for the treatment of prostate cancer.
|
Academic Article
|
ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer.
|
Academic Article
|
Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy.
|
Academic Article
|
Dosimetric influence of seed spacers and end-weld thickness for permanent prostate brachytherapy.
|
Academic Article
|
MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapy.
|
Academic Article
|
Magnetic resonance image guided brachytherapy.
|
Academic Article
|
Response to Drs Rogers, Hayes, and Demanes.
|
Academic Article
|
ACR Appropriateness Criteria? Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer.
|
Academic Article
|
Establishing high-quality prostate brachytherapy using a phantom simulator training program.
|
Academic Article
|
Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil.
|
Academic Article
|
Brachytherapy: where has it gone?
|
Academic Article
|
Impact of Insurance Status on Radiation Treatment Modality Selection Among Potential Candidates for Prostate, Breast, or Gynecologic Brachytherapy.
|
Academic Article
|
Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy.
|
Academic Article
|
Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.
|
Academic Article
|
PMMA/SWCNTs nanocomposites for prostate brachytherapy MRI contrast agent markers
|
Academic Article
|
Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy
|
Academic Article
|
Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing
|
Academic Article
|
Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy
|
Academic Article
|
American Brachytherapy Society Task Group Report
|
Academic Article
|
Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients
|
Academic Article
|
Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy
|
Academic Article
|
Permanent prostate brachytherapy pubic arch evaluation with diagnostic magnetic resonance imaging.
|
Academic Article
|
Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessment.
|
Academic Article
|
Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experience.
|
Academic Article
|
Communicating Value in Health Care Using Radar Charts: A Case Study of Prostate Cancer.
|
Academic Article
|
Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy.
|
Academic Article
|
Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancer.
|
Academic Article
|
Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers.
|
Academic Article
|
Bending the slope of the brachytherapy curve: Magnetic resonance imaging-assisted radiosurgery for the treatment of prostate cancer.
|
Academic Article
|
Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer.
|
Academic Article
|
Use of magnetic resonance imaging in low-dose-rate and high-dose-rate prostate brachytherapy from diagnosis to treatment assessment: Defining the knowledge gaps, technical challenges, and barriers to implementation.
|
Academic Article
|
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort.
|
Academic Article
|
Comparison of prostate distortion by inflatable and rigid endorectal MRI coils in permanent prostate brachytherapy imaging.
|
Academic Article
|
Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer.
|
Academic Article
|
Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes.
|
Academic Article
|
Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study.
|
Academic Article
|
MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life.
|
Academic Article
|
Parallel imaging compressed sensing for accelerated imaging and improved signal-to-noise ratio in MRI-based postimplant dosimetry of prostate brachytherapy.
|
Academic Article
|
Development and clinical implementation of SeedNet: A sliding-window convolutional neural network for radioactive seed identification in MRI-assisted radiosurgery (MARS).
|
Academic Article
|
Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing.
|
Academic Article
|
Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends.
|
Academic Article
|
Developing an intraoperative 3T MRI-guided brachytherapy program within a diagnostic imaging suite: Methods, process workflow, and value-based analysis.
|
Academic Article
|
MRI-assisted radiosurgery: A quality assurance nomogram for palladium-103 and iodine-125 prostate brachytherapy.
|
Academic Article
|
Quality comparison between three-dimensional T2-weighted SPACE and two-dimensional T2-weighted turbo spin echo magnetic resonance images for the brachytherapy planning evaluation of prostate and periprostatic anatomy.
|
Academic Article
|
A biochemical definition of cure after brachytherapy for prostate cancer.
|
Academic Article
|
Machine Segmentation of Pelvic Anatomy in MRI-Assisted Radiosurgery (MARS) for Prostate Cancer Brachytherapy.
|
Academic Article
|
Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy.
|
Academic Article
|
Development, implementation, and outcomes of a simulation-based medical education (SBME) prostate brachytherapy workshop for radiation oncology residents.
|
Academic Article
|
Fully Balanced SSFP Without an Endorectal Coil for Postimplant QA of MRI-Assisted Radiosurgery (MARS) of Prostate Cancer: A Prospective Study.
|
Academic Article
|
The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance.
|
Academic Article
|
Influence of Geography on Prostate Cancer Treatment.
|
Academic Article
|
Improving efficiency and reducing costs of MRI-Guided prostate brachytherapy using Time-Driven Activity-Based costing.
|
Academic Article
|
Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement.
|
Academic Article
|
American Brachytherapy Society radiation oncology alternative payment model task force: Quality measures and metrics for brachytherapy.
|
Academic Article
|
Computer-aided segmentation on MRI for prostate radiotherapy, Part I: Quantifying human interobserver variability of the prostate and organs at risk and its impact on radiation dosimetry.
|
Academic Article
|
Driving accountable care with brachytherapy.
|
Academic Article
|
A CALL TO ARMS: The Case for MRI-Assisted Radiosurgery (MARS) vs. Stereotactic Body Radiation Therapy or Robotic-Assisted Radical Prostatectomy.
|
Academic Article
|
Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study.
|
Academic Article
|
Evidence Based Strategies in the Management of Localized Prostate Cancer and the Role of Brachytherapy.
|
Academic Article
|
Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.
|
Academic Article
|
Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.
|
Academic Article
|
Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry.
|